Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS ClinicalTrials.gov record update

Transformative Research in Diabetic Nephropathy 2.0: A Proof of Principle Study of SGLT2 Inhibitors (TRIDENT 2.0)

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Open original source record ↗

Record identity and dates

Source
ClinicalTrials.gov
Source record ID
NCT07444203
Title field or adapter rule
protocolSection.identificationModule.officialTitle
Ingested At
2026-04-25T22:28:19.222602+00:00
Published At
2026-03-02T00:00:00+00:00
Record Updated At
2026-03-02
Timestamp Basis
source retrieval time was not retained by the feed adapter
Date limitation
source retrieval time was not retained by the feed adapter

Fields recorded by this source

protocolSection.conditionsModule.conditions
["Diabetic Nephropathies", "Kidney Diseases", "Renal Insufficiency, Chronic", "Diabetes Mellitus, Type 2"]
protocolSection.statusModule.lastUpdatePostDateStruct.date
"2026-03-02"
protocolSection.identificationModule.nctId
"NCT07444203"
protocolSection.identificationModule.officialTitle
"Transformative Research in Diabetic Nephropathy 2.0: A Proof of Principle Study of SGLT2 Inhibitors (TRIDENT 2.0)"
protocolSection.statusModule.overallStatus
"RECRUITING"
protocolSection.designModule.phases
[]
protocolSection.statusModule.resultsFirstPostDateStruct.date
""

Study condition terms

  • Diabetic Nephropathies (protocolSection.conditionsModule.conditions)
  • Kidney Diseases (protocolSection.conditionsModule.conditions)
  • Renal Insufficiency, Chronic (protocolSection.conditionsModule.conditions)
  • Diabetes Mellitus, Type 2 (protocolSection.conditionsModule.conditions)

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.